
The Effective Statistician - in association with PSI
RWE and JCA - how do they go together
Episode guests
Podcast summary created with Snipd AI
Quick takeaways
- Real-world evidence (RWE) is essential for improving treatment comparisons in healthcare, particularly for Joint Clinical Advice (JCA) when RCT data is lacking.
- Addressing potential biases in non-randomized studies requires early planning and integrated evidence strategies to ensure reliable outcomes during drug development.
Deep dives
The Importance of Real-World Evidence in HTA and JCA
Real-world evidence (RWE) plays a crucial role in the healthcare landscape, especially when randomized controlled trial (RCT) data is unavailable. This is particularly significant for the Joint Clinical Advice (JCA) process, where new drugs need effective comparators against existing treatments. RWE can provide valuable insights for these comparators, helping to avoid biases that arise from using outdated RCT data, ensuring that healthcare providers can make informed decisions based on the most current population and treatment standards. The podcast emphasizes the importance of structured workflows that facilitate data collection and analysis to appropriately answer the necessary questions presented in the JCA context, allowing for a comprehensive and evidence-based approach to treatment evaluation.